About
Jordan Koehn, Ph.D., co-founded ForagR Medicines in collaboration with Kevin Weeks, Ph.D., and Andrea Epperly, Ph.D. Established in 2024, ForagR Medicines is dedicated to advancing RNA-targeted small-molecule therapeutics, offering a groundbreaking approach to addressing some of the most complex challenges in human health. As Head of Platform and Chemical Genomics, he leads the company’s drug discovery platform, steering innovative research that aims to create transformative therapies. His contributions are at the core of ForagR’s mission to leverage RNA’s potential, developing solutions to target diseases that traditional therapies struggle to address.
Badges
Gone streaking